Stock CLPT CLEARPOINT NEURO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Market Closed - Nasdaq
Other stock markets
 01:30:00 22/06/2024 am IST 		5-day change 1st Jan Change
5.65 USD +1.99% Intraday chart for ClearPoint Neuro, Inc. +4.44% -16.79%
20/06 Clinical Laserthermia Systems Gets Additional SEK7.5 Million Orders from ClearPoint Neuro MT
04/06 ClearPoint Neuro, Inc. Initiates Its Full Market Release of the Smartframe CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now Completed
AQ
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
AQ
Clinical Laserthermia Systems Gets Additional SEK7.5 Million Orders from ClearPoint Neuro
MT
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
AQ
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
PR
CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million
AQ
BioStock: CLS' partner initiates full market release in the US
AQ
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
AQ
ClearPoint Neuro, Inc. Initiates Its Full Market Release of the Smartframe
CI
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
AQ
Clearpoint Neuro Announces Full Market Release of Smartframe or and Clearpoint Prism 3T Laser Therapy System
CI
CLS publishes interim report January - March 2024
AQ
Certain Common Stock of ClearPoint Neuro, Inc. are subject to a Lock-Up Agreement Ending on 29-MAY-2024.
CI
Certain restricted stock units of ClearPoint Neuro, Inc. are subject to a Lock-Up Agreement Ending on 29-MAY-2024.
CI
Certain stock options of ClearPoint Neuro, Inc. are subject to a Lock-Up Agreement Ending on 29-MAY-2024.
CI
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings
AQ
ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M
MT
Transcript : ClearPoint Neuro, Inc., Q1 2024 Earnings Call, May 07, 2024
ClearPoint Neuro Reports First Quarter 2024 Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLPT Stock
  4. News ClearPoint Neuro, Inc.